Erratum to: Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option (Breast Cancer Res Treat, (2012) 134, 511–517, 10.1007/s10549-012-2079-4)

Ziyan Yuan Pessetto, Ying Yan, Tadayoshi Bessho, Amarnath Natarajan

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Erratum to: Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option (Breast Cancer Res Treat, (2012) 134, 511–517, 10.1007/s10549-012-2079-4)'. Together they form a unique fingerprint.